CNSL — Cambridge Nutritional Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- £9.40m
- £5.22m
- £7.55m
- 25
- 40
- 91
- 51
Annual cashflow statement for Cambridge Nutritional Sciences, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.974 | -6.83 | 0.385 | -1.41 | -3.17 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.939 | 6.88 | -2.94 | -4.58 | -0.523 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.14 | -0.655 | -0.746 | 1.47 | -0.048 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.369 | 0.548 | -2.42 | -3.23 | -3.15 |
| Capital Expenditures | -2.69 | -2.15 | -2.83 | -1.48 | -0.153 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.8 | 0 | 0 | 0.985 | 5.33 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.894 | -2.15 | -2.83 | -0.493 | 5.18 |
| Financing Cash Flow Items | -0.097 | -0.382 | -0.769 | -0.18 | -0.303 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.535 | 1.64 | 11.1 | -0.502 | 1.49 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.116 | 0 | 5.83 | -4.22 | 3.51 |